A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how ...
Daraxonrasib doubles survival — a RAS‑targeting drug development breakthrough.
A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 ...
A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were ...
For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic ...
CDT Biocartis Announces Agreement with City of Hope to Explore Development of Rapid Gene Signature Test for Early Detection ...
Enhancing Readability of Lay Abstracts and Summaries for Urologic Oncology Literature Using Generative Artificial Intelligence: BRIDGE-AI 6 Randomized Controlled Trial We trained and tested ML systems ...
Short-Term Surgical Mission in Sub-Saharan Country, Experience of a Breast-Dedicated Team: Reviewing the Past and Stepping Toward the Last Mission Rapidly expanding systemic treatment options, ...
Oxford University and Moderna launch trials of vaccine that could prevent cancer - The jab targets patients with Lynch ...
Share on Pinterest Scientists are looking at the effects of the keto diet on cancer therapies. Dulin/Getty Images A ketogenic diet can interact with certain cancer therapies to block the development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results